Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Salt Lake City, Utah

Phase 1 colorectal cancer trials in Salt Lake City, UT

16 Phase 1 colorectal cancer studies are recruiting participants at sites in Salt Lake City as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Salt Lake City at a glance

  • 16 studies are recruiting at a site in Salt Lake City.
  • By phase: Phase 1 (7), Phase 1/2 (9).
  • By sponsor: industry (15), university, hospital or other (1).
  • Most recent update to one of these records: November 17, 2026.

Studies recruiting in Salt Lake City

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Aktis Oncology, Inc.
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT07020117 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Huntsman Cancer Institute University of Utah
    Registry record
    NCT07488676 · updated
  3. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT07458347 · updated
  4. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT07020221 · updated
  5. A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    University of Utah - Huntsman Cancer Institute
    Registry record
    NCT07542704 · updated
  6. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study sites
    University of Utah Health Huntsman Cancer Hospital · Utah Cancer Specialists
    Registry record
    NCT03526835 · updated
  7. A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT06330064 · updated
  8. JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Jacobio Pharmaceuticals Co., Ltd.
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT06973564 · updated
  9. A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Dispatch Biotherapeutics
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT07544589 · updated
  10. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT06445062 · updated
  11. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    START Mountain Region
    Registry record
    NCT06131840 · updated
  12. A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Coherus Oncology, Inc.
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT06657144 · updated
  13. Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Recursion Pharmaceuticals Inc.
    Study site
    Huntsman Cancer Institute and University of Utah
    Registry record
    NCT05552755 · updated
  14. BBO-11818 in Adult Subjects With KRAS Mutant Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT06917079 · updated
  15. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT05379985 · updated
  16. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    858 Therapeutics, Inc.
    Study site
    START Center for Cancer Care - Mountain Region
    Registry record
    NCT06395519 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Salt Lake City, UT on ClinicalTrials.gov.

Ask about studies near Salt Lake City

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Utah

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call